GridAI Technologies (GRDX) Price to Book (2025 - 2026)
GridAI Technologies' (GRDX) quarterly Price to Book came in at 2.18 in Q2 2026, up 621.51% quarter-over-quarter from 0.3 in Q4 2025.
Powered by 
Analysis
GridAI Technologies (GRDX) Price to Book (2025 - 2026) Analysis & Trends
GridAI Technologies (GRDX) has reported Price to Book for 2 consecutive years, with 2.18 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Price to Book changed N/A year-over-year to 2.18; the trailing twelve-month figure through Jun 2026 stood at 2.18 (changed N/A YoY), and the FY2025 full-year result was 0.3, changed N/A from the prior year.
- Price to Book advanced to 2.18 in Q2 2026 per GRDX's latest filing, from 0.3 in the prior quarter.
- Across five years, Price to Book topped out at 2.18 in Q2 2026 and bottomed at 0.3 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | GridAI Technologies | 19.07 Mn | 19.07 Mn | -36,514.00 |